Article Details

Bamlanivimab Monotherapy No Longer Authorized for COVID-19 Treatment

Retrieved on: 2021-04-19 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Bamlanivimab Monotherapy No Longer Authorized for COVID-19 Treatment. View article details on hiswai:

Excerpt

Alternative authorized monoclonal antibody therapies remain available for the treatment of COVID-19. These include casirivimab in combination with ...

Article found on: www.empr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo